Suven Pharmaceuticals' Stock Sees Decline of -3.31% on November 7, Rated as 'Hold' by MarketsMOJO

Suven Pharmaceuticals, a leading player in the pharmaceuticals and drugs industry, has seen a decline in its stock price by -3.31% on November 7, 2024. This has been reflected in the stock call given by MarketsMOJO, which has rated the stock as 'Hold'. The stock has underperformed the sector by -1.91% and has been on a consecutive fall for the last two days, with a decline of -3.87% in this period. On the day of the decline, the stock touched an intraday low of Rs 1280.05, which is a decrease of -3.42%. Despite the recent decline, Suven Pharmaceuticals' moving averages are still higher than the 20-day, 50-day, 100-day, and 200-day moving averages. However, it is lower than the 5-day moving average. In comparison to the Sensex performance, Suven Pharmaceuticals' 1-day performance is -3.42%, while the Sensex has only seen a decline of -1.04%. Over the past month, Suven Pharmaceuticals has outperformed the Sensex with a 10.84% increase, while the Sensex has seen a decline of -1.86%. Overall, Suven Pharmaceuticals' stock has seen a recent decline, but it still remains a strong player in the pharmaceuticals and drugs industry. Investors should keep an eye on the stock's performance in the coming days.